The 9-11 probe

As virtually his last official act as the Republican leader in the Senate, Trent Lott, bowing to White House pressure, stiffed the 9-11 victims’ families by not appointing Warren Rudman to the 9-11 commission. It’s fair to ask what the White House was afraid of. Meanwhile, it turns out that former New Jersey Governor Thomas Kean, who has no obvious qualifications for dealing with the issues before the Commission, is on the board of Amerada Hess, which does extensive business with Saudi Arabia. Now that’s reassuring.

Author: Mark Kleiman

Professor of Public Policy at the NYU Marron Institute for Urban Management and editor of the Journal of Drug Policy Analysis. Teaches about the methods of policy analysis about drug abuse control and crime control policy, working out the implications of two principles: that swift and certain sanctions don't have to be severe to be effective, and that well-designed threats usually don't have to be carried out. Books: Drugs and Drug Policy: What Everyone Needs to Know (with Jonathan Caulkins and Angela Hawken) When Brute Force Fails: How to Have Less Crime and Less Punishment (Princeton, 2009; named one of the "books of the year" by The Economist Against Excess: Drug Policy for Results (Basic, 1993) Marijuana: Costs of Abuse, Costs of Control (Greenwood, 1989) UCLA Homepage Curriculum Vitae Contact: Markarkleiman-at-gmail.com